Positron Emission Tomography in Breast Cancer
Open Access
- 16 March 2015
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 5 (1) , 61-83
Abstract
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological diseases. In many of these, PET/CT has shown to be useful at different stages of the disease: diagnosis, staging or re-staging, treatment response assessment, and recurrence. Some of the advantages of this imaging modality versus CT, MRI, bone scan, mammography, or ultrasound, are based on its great diagnostic capacity since, according to the radiopharmaceutical used, it reflects metabolic changes that often occur before morphological changes and therefore allows us to stage at diagnosis. Moreover, another advantage of this technique is that it allows us to evaluate the whole body so it can be very useful for the detection of distant disease. With regard to breast cancer, FDG-PET/CT has proven to be important when recurrence is suspected or in the evaluation of treatment response. The technological advancement of PET equipment through the development of new detectors and equipment designed specifically for breast imaging, and the development of more specific radiopharmaceuticals for the study of the different biological processes of breast cancer, will allow progress not only in making the diagnosis of the disease at an early stage but also in enabling personalized therapy for patients with breast cancer.Keywords
This publication has 92 references indexed in Scilit:
- Comparison of the Diagnostic Value of FDG-PET/CT and Axillary Ultrasound for the Detection of Lymph Node Metastases in Breast Cancer PatientsActa Radiologica, 2012
- Early bone marrow metastasis detection: The additional value of FDG-PET/CT vs. CT imagingBiomedicine & Pharmacotherapy, 2012
- Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PETJournal of Oncology, 2012
- Advances in molecular imaging for breast cancer detection and characterizationBreast Cancer Research, 2012
- The Effects of Preoperative18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging StudyJournal of Breast Cancer, 2012
- Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral BreastRadiology, 2011
- Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II–III breast cancerEuropean Journal of Cancer, 2010
- Prevention of Brown Adipose Tissue Activation in 18F-FDG PET/CT of Breast Cancer Patients Receiving Neoadjuvant Systemic TherapyJournal of Nuclear Medicine Technology, 2010
- Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortBMC Cancer, 2009
- Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine, 2008